Agent: Michael P. Morris Boehringer Ingelheim Usa Corporation20090227587 - Pyrimidines as inhibitors of phosphoinositide-3-kinases (pi3k): wherein R4, R6, and Y have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cardiovascular diseases, a